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Introduction 
Systemic lupus erythematosus (SLE) is associated with a higher prevalence and a more 
rapid progression of atherosclerosis than the general population (1,2). Studies have 
shown that lupus patients present a 5-to-6 fold increased risk of coronary and cere-
brovascular diseases, and an enhanced cardiovascular mortality (1-4). Moreover, approxi-
mately 30% of lupus patients have subclinical atherosclerosis, as the patient age in-
creases at diagnosis, longer is the duration of the disease (2,3). 
Atherosclerotic process is the most common cause of renal artery stenosis in the adult-
hood. Although atherosclerosis is a well-known complication of SLE, only small amounts 
of data exist about the coexistence of SLE and renal artery stenosis. Most cases show 
unilateral involvement, impaired kidney function, renal infarction or association with 
antiphospholipid antibodies (5,6).  
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SUMMARY 
Systemic lupus erythematosus (SLE) is associated with a high prevalence of atherosclero-
sis and an enhanced cardiovascular mortality. In adult subjects, several studies have 
shown the coexistence of SLE and renal artery stenosis, most of them with unilateral in-
volvement or with renal dysfunction. 
We observed a 62-year-old man with SLE and a 10-year history of moderate-to-severe hy-
pertension who was admitted to our hospital because of uncontrolled blood pressure val-
ues (152/95 mmHg), despite drug therapy.  No signs of renal impairment were evident. 
After an initial physical examination, which presented a periumbilical bruit, a renal ultra-
sound was performed with evidence of bilateral renal artery stenosis. An angio-MR study 
also confirmed the diagnosis and showed a double renal artery on the right side. 
Many different factors can contribute to the bilateral renal artery stenosis in this patient. 
Chronic inflammatory state associated to SLE, metabolic alterations with dyslipidemia and 
steroid therapy may all be involved in the development of the renal atherosclerotic le-
sions.  
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We observed a lupus patient with high 
blood pressure values and bilateral steno-
sis of renal arteries without deterioration 
of renal function and with no evidence of 
antiphospholipid-antibodies or lupus anti-
coagulant (LAC). 
 
Case history 
A 62-year-old man with SLE, diagnosed by 
skin biopsy about 20 years ago, and a 10-
years history of moderate-to-severe hyper-
tension, treated with amlodipine 5 mg/day, 
was admitted to our Hypertension Unit 
because of high blood pressure values. A 
history of steroid-induced diabetes compli-
cated by mixed peripheral neuropathy, 
osteoporosis and dyslipidemia was also 
present. No signs of renal function impair-
ment were evident. 
Body mass index, blood pressure (BP) and 
heart rate were respectively 23.6 Kg/m
2
, 
152/95 mmHg and 64 bpm. Physical ex-
amination did not detect anything abnor-
mal, except for a holosystolic bruit in right 
periumbilical area. 
Laboratory tests showed: hemoglobin 11.8 
g/dl, BUN 34 mg/dl, creatinine 0.7 mg/dl, 
eGFR (EPI) 119 ml/min/1.73m
2
, serum 
sodium 136 mEq/L, serum potassium 4.0 
mEq/L, serum total calcium 8.3 mg/dl, 
total cholesterol 178 mg/dl, c-HDL 35 mg/
dl, c-LDL 113 mg/dl, triglycerides 152 mg/
dl, serum glucose 150 mg/dl, HbA1c 6%, 
serum uric acid 6.1 mg/dl, ESR 16 mm/h, 
CRP 1.8 mg/L, and negative antinuclear, 
anti-double-stranded deoxyribonucleic acid 
(dsDNA), antiphospholipid and anti-β2 
glycoprotein antibodies, as well as LAC. 
Normal values were observed regarding 
standard urinalysis, 24-h albumin excre-
tion rate, plasma renin activity (0.5 ng/ml/
h) and plasma aldosterone levels (96 pg/
ml), both assessed in a recumbent position 
and after a two-weeks antihypertensive 
pharmacological washout.  
A 24-h ambulatory blood pressure moni-
toring during treatment with calcium chan-
nel blockers showed the following average 
BP values: daytime BP 147/87 mmHg and 
nighttime BP 122/70 mmHg. Therefore, 
the circadian BP variability was normal 
(dipper pattern). The aortic pulse wave 
velocity (12.68 m/s) and aortic augmenta-
tion index (42.74%) were also measured by 
using the Arteriograph device (Tensiomed 
Kft., Budapest, Hungary). A Doppler ultra-
sonographic evaluation of the carotid arter-
ies revealed the presence of bilateral calci-
fied non-stenotic plaques on both sides, 
and the carotid intima-media thickness 
(IMT) was 1.0 mm.  
A renal ecography with Doppler integration 
was also performed. It showed a normal 
kidney size and structure, with reduced 
blood flow velocities but normal values of 
resistive (RI) and pulsatility (PI) indexes. 
The examination of the renal artery ostia 
also revealed reduced vessel diameters 
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Figure 1: Upper abdomen angio-MR (A) and renal arteries in detail (B). Left renal artery 
shows a 65% stenosis at about 8 mm from its origin, extending for 5-6 mm. On the right 
side, a double renal artery is present, with a 90% stenosis of most of the caudal artery  
bilaterally (right: 0.39 cm; left: 0.43 cm), 
with no significant differences between the 
two sides; in addition, elevated peak sys-
tolic velocities (PSV=317 cm/s to the right; 
PSV=218 cm/s to the left) and increased 
reno-aortic ratio values (RAR=3.6 on the 
right; RAR=2.5 on the left) were found. 
Therefore, the patient underwent a renal 
vessels angio-MR, that confirmed the pres-
ence of bilateral renal artery stenosis 
(right:90 %; left:65%) and showed the pres-
ence of a double right renal artery (Figure 
1). 
The patient refused to undergo any further 
invasive procedures. Therefore, a more 
appropriate pharmacological therapy 
(amlodipine 10 mg/day, losartan 50 mg/
day and chlorthalidone 25 mg twice a 
week) has been initiated and a 1-year fol-
low-up has been carried out, with satisfac-
tory results regarding BP values and renal 
function. 
 
Discussion 
Atherosclerotic disease is currently recog-
nized as the most common cause of renal 
artery stenosis in adults. Numerous stud-
ies show that atherosclerotic damage has a 
higher incidence, extension and progres-
sion in patients with chronic autoimmune 
disease compared to the general popula-
tion (1-4). Even if there is substantial data 
regarding the presence of unilateral renal 
artery stenosis in lupus patients, very few 
cases are reported about the coexistence 
of bilateral renal arterial stenosis and SLE. 
Moreover, in all these cases, an impaired 
renal function or renal infarction have 
been described (5,6). 
The presence of bilateral renal arterial 
stenosis in a hypertensive patient with SLE 
without renal impairment has no prece-
dent in the literature. If this association is 
casual or causal has not been established. 
However, there is evidence that support 
the latter hypothesis. 
First, some studies emphasize the impor-
tance of the chronic inflammation on the 
genesis of the lesions (2,3,7). Several in-
flammatory mediators, in particular cyto-
kines overexpressed in lupus patients such 
as IFN-1, TNF-alfa and low levels of TGF-
beta act by altering the processes of endo-
thelial repair, by promoting the migration 
and the proliferation of vascular smooth 
muscle cells and by recruiting inflamma-
tory cells. This leads to induction, accel-
eration and progression of the atheroscle-
rotic lesions, thus contributing to the in-
creased cardiovascular risk in patients with 
SLE (7,8). 
Dyslipidemia is also an important factor 
involved in atherosclerosis in SLE (3,9). 
Substantial data, in fact, show that lupus 
patients, with or without renal dysfunction, 
have a greater metabolic derangement 
than the general population (9). Chronic 
inflammatory states, as well as prolonged 
steroid therapy, contribute to altering the 
lipid metabolism. The resulting dyslipide-
mia facilitates the formation of plaques, 
according to the classical model of athero-
sclerosis. 
Moreover, the same steroid therapy, as 
well as a non-aggressive immunosuppres-
sive therapy, may further contribute to the 
development of vascular wall damage, 
although conflicting data exists in the 
literature. In fact, sustained steroid therapy 
could determine medial necrosis, because 
of connective tissue disintegration, thus 
creating a minoris resistentiae area more 
susceptible to local hemodynamic injury
(10). 
In conclusion, the presence of bilateral 
renal artery stenosis in our patient seems 
to have pathogenetic and pathophysiologi-
cal connections with SLE. Although these 
assumptions seem to be in agreement with 
the literature, further studies are necessary 
to confirm the mechanisms we proposed 
to explain this unusual vascular finding. 
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